• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
Displaying 54-68 of 12,971 results

No. 12 NOTICE OF NON-COMPLIANCE: The submission of Appellee Janssen Biotech, Inc., Entry of Appearance ...

Document Pharmacyclics LLC v. Alvogen, Inc., 21-2270, No. 12 (Fed. Cir. Sep. 15, 2021)
Your submitted document (Entry of Appearance) is not in compliance with the rules of this court.
Within five business days from the date of this notice, please submit a corrected version of this document correcting the following: • The contact information for Christine Willgoos on the form does not match the information associated with the user's account.
Please ensure the corrected appearance form contains up-to-date contact information.
A party's failure to timely file a corrected document curing all defects identified on this notice may result in this document being stricken.
An appellant or petitioner's failure to cure a defective filing may also result in the dismissal of the appeal.
cite Cite Document
Analyze

No. 3 Certificate of Interest for Appellee Pharmacyclics LLC

Document Pharmacyclics LLC v. Alvogen, Inc., 21-2270, No. 3 (Fed. Cir. Sep. 14, 2021)
... Ward (Morris, Nichols, Arsht & Tunnell LLP) The title and number of any case known to me to be pending in this or any other court or agency that will directly affect or be directly affected by this court’s decision in the pending appeal: None.
cite Cite Document
Analyze

No. 9 Certificate of Interest for Appellants Alvogen Pine Brook, LLC and Natco Pharma Limited

Document Pharmacyclics LLC v. Alvogen, Inc., 21-2270, No. 9 (Fed. Cir. Sep. 14, 2021)
(cid:1798) None/Not Applicable (cid:1798) None/Not Applicable Alvogen Pine Brook, LLC Alvogen, Inc.
None/Not Applicable None/Not Applicable ✔ Additional pages attached Case: 21-2270 Document: 9 Page: 3 Filed: 09/14/2021 FORM 9.
None/Not Applicable Additional pages attached Proskauer Rose LLP: Gourdin W. Sirles Proskauer Rose LLP: Michelle M. Ovanesian Proskauer Rose LLP: Kimberly Q. Li Proskauer Rose LLP: Christopher D. Lynch Proskauer Rose LLP: ...
None/Not Applicable Additional pages attached ✔ 6.
None/Not Applicable Additional pages attached ✔ Case: 21-2270 Document: 9 Page: 4 Filed: 09/14/2021 3.
cite Cite Document
Analyze
+ More Snippets

No. 6 Certificate of Interest for Appellee Janssen Biotech, Inc

Document Pharmacyclics LLC v. Alvogen, Inc., 21-2270, No. 6 (Fed. Cir. Sep. 14, 2021)
☐ None/Not Applicable ☐ None/Not Applicable Additional pages attached 4 Janssen Biotech, Inc.
None/Not Applicable Additional pages attached 5.
None/Not Applicable Additional pages attached 6.
None/Not Applicable Additional pages attached Daniel Williams of Kramer Levin Naftalis & Frankel LLP Marcus Colucci of Kramer Levin Naftalis & Frankel LLP Cristina Martinez of Kramer Levin Naftalis & Frankel LLP Jonathan Pepin of ...
cite Cite Document
Analyze
+ More Snippets

No. 7 Docketing Statement for the Appellee Janssen Biotech, Inc

Document Pharmacyclics LLC v. Alvogen, Inc., 21-2270, No. 7 (Fed. Cir. Sep. 14, 2021)
) Originating Number 1:19-cv-434-CFC-CJB 1:19-cv-434-CFC-CJB Type of Case Patent Patent Relief sought on appeal: q None/Not Applicable Affirmance of the district court judgment.
Relief awarded below (if damages, specify): q None/Not Applicable The district court enjoined Defendants from manufacturing, using, selling, or offering for sale in the United States or importing The district court enjoined Defendants from ...
El None/Not Applicable ✔ Issues to be raised on appeal: El None/Not Applicable 1.
None. None.
cite Cite Document
Analyze
+ More Snippets

No. 2 Entry of appearance for Christopher N. Sipes; Erica N. Andersen; Brianne Bharkhda; Laura E. ...

Document Pharmacyclics LLC v. Alvogen, Inc., 21-2270, No. 2 (Fed. Cir. Sep. 14, 2021)
Case Number: Short Case Caption: 2021-2270 Pharmacyclics LLC v. Alvogen Pine Brook, LLC Instructions: Refer to Fed. Cir. R. 47.3 for requirements governing representation and appearance in this court.
Non-admitted government counsel should enter N/A in lieu of an admission date.
List all parties, intervenors, amicus curiae, or movants represented by below counsel; “et al.” is not permitted.
Pharmacyclics LLC Admission Date: 12/08/98 Principal Counsel: Christopher N. Sipes Firm/Agency/Org.
Admission Date: 06/06/11 Other Counsel: Brianne Bharkhda Firm/Agency/Org.
cite Cite Document
Analyze

No. 8 Entry of appearance for Siegmund Y. Gutman; John E. Roberts; Amir A. Naini; David M. Hanna ...

Document Pharmacyclics LLC v. Alvogen, Inc., 21-2270, No. 8 (Fed. Cir. Sep. 14, 2021)
Pharmacyclics LLC v. Alvogen Pine Brook, LLC Instructions: Refer to Fed. Cir. R. 47.3 for requirements governing representation and appearance in this court.
Counsel must immediately file an amended Entry of Appearance if contact information changes and update information through PACER’s Manage My Account.
Non-admitted government counsel should enter N/A in lieu of an admission date.
List all parties, intervenors, amicus curiae, or movants represented by below counsel; “et al.” is not permitted.
Admission Date: 11/06/2008 Alvogen Pine Brook, LLC; Natco Pharma Ltd. Siegmund Y. Gutman Principal Counsel: Proskauer Rose LLP Firm/Agency/Org.
cite Cite Document
Analyze

No. 4 Docketing Statement for the Appellee Pharmacyclics LLC

Document Pharmacyclics LLC v. Alvogen, Inc., 21-2270, No. 4 (Fed. Cir. Sep. 14, 2021)
None.
cite Cite Document
Analyze

No. 5 Entry of appearance for Irena Royzman; Hannah Lee; Christine Willgoos as counsel for Appellee ...

Document Pharmacyclics LLC v. Alvogen, Inc., 21-2270, No. 5 (Fed. Cir. Sep. 14, 2021)
Case Number: Short Case Caption: Instructions: Refer to Fed. Cir. R. 47.3 for requirements governing representation and appearance in this court.
Counsel must immediately file an amended Entry of Appearance if contact information changes and update information through PACER’s Manage My Account.
Non-admitted government counsel should enter N/A in lieu of an admission date.
List all parties, intervenors, amicus curiae, or movants represented by below counsel; “et al.” is not permitted.
: Address: Admission Date: Email: Admission Date: Email: Phone: I certify under penalty of perjury that (1) the submitted information is true and accurate and (2) I am authorized to enter an appearance by all other listed counsel.
cite Cite Document
Analyze

No. 10

Document Pharmacyclics LLC v. Alvogen, Inc., 21-2270, No. 10 (Fed. Cir. Sep. 14, 2021)

cite Cite Document
Analyze

SERUM-FREE CELL CULTURE MEDIUM

Docket 17/712,697, U.S. Patent Application (April 4, 2022)

cite Cite Docket
Analyze

ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE S...

Docket 17/711,723, U.S. Patent Application (April 1, 2022)

cite Cite Docket
Analyze

Reexamination of Patent No. 8,280,009, Consumer Electronic Registration, Contro...

Docket 90/14,991, U.S. Patent Application (March 29, 2022)

cite Cite Docket
Analyze

BIOLOGICAL VALVE FOR VENOUS INSUFFICIENCY

Docket 17/706,533, U.S. Patent Application (March 28, 2022)

cite Cite Docket
Analyze

TRAVEL AND ORIENTATION MONITOR APPARATUS FOR FIREFIGHTERS AND R...

Docket 17/687,957, U.S. Patent Application (March 7, 2022)

cite Cite Docket
Analyze
<< 1 2 3 4 5 6 7 8 ... >>